Rachel Strasser
Family · la Crosse, WINPI 1588107544
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,692 of the $2,792 with a category attached, or 60.6%. Atricure, Inc. accounts for 77.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,153 and has fallen 76.1% since, to $515 in 2025. Among family clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $73.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- AbbVie$199
- E.r. Squibb & Sons, L.L.C.$125
- Novo Nordisk$118
- Vertex$33
- GSK$31
- plus $133 from 6 others
What the payments were for
- Travel & lodging$1,69261%
- Food & beverage$1,10139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 13 | $2,153 |
| AbbVie | 10 | $199 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Novo Nordisk | 5 | $118 |
| Vertex | 2 | $33 |
| GSK | 1 | $31 |
| Lundbeck LLC | 1 | $31 |
| Exact Sciences | 1 | $30 |
| AstraZeneca | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,792 in reported general payments places this provider in the 90th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 34 | $30,557 |
| Metoprolol Succinate | 24 | $319 |
| Atorvastatin Calcium | 21 | $258 |
| Mupirocin | 27 | $157 |
| Metoprolol Tartrate | 20 | $68 |
| Furosemide | 12 | $63 |
| Amoxicillin | 62 | $47 |
| Doxycycline Monohydrate | 12 | $26 |
| Allopurinol | 22 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in la Crosse
- Allison Andreasla Crosse$5K
- Stephanie OffordMilwaukee$116K
- Laura SwobodaMenomonee Falls$111K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.